• AstraZeneca nabs next-gen oral PCSK9 inhibitor asset from Dogma Therapeutics

    11 days ago - By Fierce Biotech

    AstraZeneca nabs next-gen oral PCSK9 inhibitor asset from Dogma Therapeutics badams
    Thu, 09/17/2020 - 03:09
    Read more ...